CHOLESTEROL BEATS SWINE FLU, AVIAN FLU AND CORONA VIRUSES: VIROBLOCK LAUNCHES NEW FACE MASK
Geneva, Switzerland, June 26, 2013-- Viroblock SA, a Swiss start-up, today presented new data at ICPIC 2013 in Geneva, showing that their face-mask containing proprietary novel cholesterol depletion technology traps and kills over 99.9995% of H1N1 flu viruses (swine flu), 99.999% of H5N1 flu viruses (avian flu) and 99.997% human corona viruses on pass through air. Aimed at helping protect people from these respiratory pathogens, the mask is up to one hundred times more effective than a similar mask without Viroblock technology. The company will now start direct sales in Switzerland and is looking for distributors in other countries.
“Aerobiology tests for face-masks simulate real life situations, in which the user is exposed to viruses coming in. The mask helps prevent transmission from and to the person wearing the mask.” commented Dr Thierry Pelet, CSO at Viroblock. “The stringent testing demonstrates the efficacy and speed at which the cholesterol depletion technology works”.
Aerobiology tests, carried out in high security laboratories, create a mist of viruses on the outside of the mask, a pump is used to draw air and viruses through the mask, and finally testing for live virus occurs on the inside of the mask.
“We believe that our protective face-mask can help protect healthcare, agriculture and security workers effectively, with added advantages of comfort of wear and easy identification,” said Dr Jamie Paterson, CEO of Viroblock.
Viroblock SA is a CTI Certified Swiss start-up located in Geneva, Switzerland. Founded in 2006 and supported mainly by Swiss investors, the company is focused on developing a unique anti-viral technology based on cholesterol depletion. Viroblock’s first product is an anti-viral face mask and other air filtration products are planned. For more information about Viroblock, please visit: www.viroblock.com. Viroblock is also available on Facebook and Twitter.
- ends -
For further information, please contact:
Danièle Castle Dr Jamie Paterson
Genevensis Communications Viroblock
T: + 41 79 202 6667 T: + 41 79 831 6006
Mail: email@example.com Mail:firstname.lastname@example.org
TTC fête ses 10 ans au Campus Biotech30.10.2017Conférence et émission filmée en direct Quand allons-nous mourir ?
Prix Perl 2018Les PERL sont devenus au fil des ans un élément central du soutien de Lausanne Région aux entreprises établies sur...
Unitechnologies SAMedical Devices, Laboratory engineering and equipment
Unitechnololgies SA is a company active in the high technology domain of precision automation. With its brands sysmelec®, mta® and sylas®, Unitechnologies develops and realizes high precision production machines for industries, such as watchmaking, medical, microelectronics, automotive and optoelectronics.
Medical Devices, Mechanical Engineering / Micro Engineering
With its sysmelec® brand, Unitechnologies designs and manufactures custom machines, mainly intended for the automated assembly of microtechnical products that are demanding in terms of precision and integrated processes. Furthermore, standardized sysmelec® systems for the crimping and packaging of surgical sutures, as well as palletizers, are proposed.
With its mta® brand, Unitechnologies globally commercializes volumetric micro-dispensing and selective soldering processes based on standardized platforms. The product range includes simple manual systems, semi-automatic table robots as well as fully automatic production cells.
With its sylas® brand, Unitechnologies has developed industrial platforms dedicated to the process automation of 3D laser surface processing such as selective polishing and micro-structuring. In additon, the sylas® platforms can also be used for other laser applications such as micro-welding, micro-cutting or marking.